Cytomegalovirus Vaccine in Healthy Participants
Completed · Phase 1
Conditions studied: Precancerous/Nonmalignant Condition
In brief
RATIONALE: Vaccines may help the body build an effective immune response against cytomegalovirus. PURPOSE: This randomized phase I trial is studying the side effects and best dose of cytomegalovirus vaccine in healthy participants.
Key facts
- Study ID
- NCT00712634
- Run by
- City of Hope Medical Center
- People needed
- 46
- Starts
- 1997-11-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2009-12-21
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.